ACCREDITATION STATUS:

UKAS schedule of accreditation

CLINICAL APPLICATION:

Primary (idiopathic) membranous nephropathy

ANALYTES:

PROGRAMME OF ANALYSIS:

Data entry is via the web for the submission of results. Data analysis is commenced 21 days after sample despatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics.

DATA ANALYSIS:

Qualitative responses are assessed by MI scoring in relation to the designated response

PERFORMANCE SCORING:

MI scoring

PERFORMANCE MONITORING:

Laboratory performance is classified in terms of OMIS over a running analytical window of 6 distributions (12 months)

PERSISTENT POOR PERFORMANCE:

Defined as being in the poor performance category for two or more successive distributions